TerminatedPhase 2NCT01059656
Phase II Pazopanib Study in Advanced Dermatofibrosarcomas
Studying Dermatofibrosarcoma protuberans
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Celeste LEBBE, MD-PhDAssistance Publique - Hôpitaux de Paris
- Intervention
- Pazopanib(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2010 – 2014
Study locations (1)
- Hôpital Saint-Louis - Service de Dermatologie (Pole POPS), Paris, France
Collaborators
GlaxoSmithKline
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01059656 on ClinicalTrials.gov